换一批Comparison of prognostic scores according to WHO classification in 170 patients with advanced mastocytosis and C-finding treated with midostaurin.
第一作者：
Maël,Heiblig
第一单位：
Hematology Department, Centre Hospitalier Lyon Sud, Pierre-Bénite, France.
作者：
Maël,Heiblig [1]
;
Clément,Gourguechon [2]
;
Philippe,Guilpain [3]
;
Cristina,Bulai-Livideanu [4]
;
Stéphane,Barete [5]
;
Yannick,Chantran [6]
;
Julie,Agopian [7]
;
Fabienne,Brenet [8]
;
Patrice,Dubreuil [8]
;
Jérémie,Lespinasse [9]
;
Richard,Lemal [10]
;
Olivier,Tournilhac [10]
;
Louis,Terriou [11]
;
David,Launay [12]
;
Laurence,Bouillet [13]
;
Catharina,Chatain [13]
;
Ghandi,Damaj [14]
;
Thomas,Ballul [15]
;
Celine,Greco [16]
;
Laura,Polivka [17]
;
Laurent,Frenzel [15]
;
Cécile,Meni [18]
;
Hassiba,Bouktit [18]
;
Dina,Benabou [18]
;
Caroline,Gaudy-Marqueste [19]
;
Marie,Gousseff [20]
;
Edwige,Le Mouel [21]
;
Antoine,Neel [22]
;
Dana,Ranta [23]
;
Roland,Jaussaud [24]
;
Thierry Jo,Molina [25]
;
Julie,Bruneau [26]
;
Patrick,Villarese [27]
;
Ludovic,Lhermitte [28]
;
Leila,Maouche-Chrétien [29]
;
Marie,Temple [30]
;
Olivier,Kosmider [30]
;
Rose-Marie,Javier [31]
;
Fabien,Pelletier [32]
;
Florence,Castelain [33]
;
Frederique,Retornaz [34]
;
Quentin,Cabrera [35]
;
Patricia,Zunic [35]
;
Marie Pierre,Gourin [36]
;
Ewa,Wierzbicka-Hainaut [37]
;
Jean François,Viallard [38]
;
Christian,Lavigne [39]
;
Cyrille,Hoarau [40]
;
Isabelle,Durieu [41]
;
Sophie,Dimicoli-Salazar [42]
;
Jose Miguel,Torregrosa-Diaz [43]
;
Mathieu,Wemeau [44]
;
Angèle,Soria [45]
;
Michel,Arock [46]
;
Christine,Bodemer [47]
;
Olivier,Lortholary [18]
;
Olivier,Hermine [48]
;
Julien,Rossignol [15]
作者单位：
Hematology Department, Centre Hospitalier Lyon Sud, Pierre-Bénite, France.
[1]
Department of Hematology, Amiens University Hospital, Amiens, France.
[2]
CEREMAST, the Department of Internal Medicine-Multi-organ Diseases, Saint-Eloi University Hospital, Montpellier University, Montpellier, France.
[3]
CEREMAST Toulouse, Dermatology Departmen, CHU de Toulouse, Toulouse, France.
[4]
Sorbonne Université, APHP, Unité Fonctionnelle de Dermatologie, Groupe Hospitalier Pitié-Salpêtrière-C. Foix, Paris, France.;French Reference Center for Mastocytosis (CEREMAST), Necker-Enfants Malades University Hospital, APHP, Paris, France.
[5]
Department of Biological Hematology, Pitié-Salpêtrière Hospital, DMU BioGem, AP-HP, Sorbonne University, Paris, France.;Department of Biological Immunology, Saint-Antoine Hospital, DMU BioGem, AP-HP, Sorbonne University, Paris, France.;Health Environmental Risk Assessment (HERA) Team, Centre of Research in Epidemiology and Statistics (CRESS), Inserm/INRAE, Faculty of Pharmacy, Université de Paris, Paris, France.
[6]
Association Française pour les Initiatives de Recherche sur le Mastocyte et les Mastocytoses (AFIRMM), Paris, France.
[7]
Centre de Recherche en Cancérologie de Marseille (CRCM) INSERM U1068, CNRS UMR7258, AMU U105, Département d'Onco-Hématologie-Immunologie, Institut Paoli-Calmettes, Marseille, France.
[8]
eXYSTAT, Malakoff, France.
[9]
Adult Clinical Hematology, Clermont-Ferrand University Hospital, INSERM CIC501, EA 7453-Université Clermont Auvergne, Clermont-Ferrand, France.
[10]
INSERM, CHU Lille, Department of Internal Medicine and Clinical Immunology, U1286 - INFINITE - Institute for Translational Research in Inflammation, University Lille, Lille, France.
[11]
INSERM, CHU Lille, Service de Médecine Interne et Immunologie Clinique, Centre de référence des maladies autoimmunes systémiques rares du Nord et Nord-Ouest de France (CeRAINO), U1286 - INFINITE - Institute for Translational Research in Inflammation, University Lille, Lille, France.
[12]
Internal Medicine Department, Grenoble Alpes University Hospital, Univ. Grenoble Alpes, T-RAIG unit, CNRS, UMR 5525, VetAgro Sup, Grenoble INP, CHU Grenoble Alpes, TIMC, Grenoble, France.
[13]
Haematology Institute, Normandy University School of Medicine, Caen, France.
[14]
French Reference Center for Mastocytosis (CEREMAST), Necker-Enfants Malades University Hospital, APHP, Paris, France.;Imagine Institute, INSERM U1163, Necker-Enfants Malades University Hospital, Paris University, Paris, France.
[15]
CEREMAST, the Department of Pain and Palliative Care Unit, Necker-Children's Hospital, AP-HP, Paris Centre University, Paris, France.
[16]
Haematology Institute, Normandy University School of Medicine, Caen, France.;Department of Dermatology, Reference Center for Genodermatoses (MAGEC), Necker Hospital for Sick Children, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris Cité University, Paris, France.;CEREMAST, the Department of Hematology, Necker-Children's Hospital, AP-HP, Paris Centre University, Paris, France.
[17]
French Reference Center for Mastocytosis (CEREMAST), Necker-Enfants Malades University Hospital, APHP, Paris, France.
[18]
Dermatology and Skin Cancer, Department, Aix-Marseille University, APHM, Marseille, France.
[19]
Department of Internal Medicine, Bretagne Atlantique Hospital, Vannes, France.
[20]
Department of Internal Medicine and Clinical Immunology, Rennes University Hospital, Rennes, France.
[21]
CEREMAST, the Department of Internal Medicine, Hôtel-Dieu University Hospital, Nantes, France.
[22]
Department of Haematology, Nancy University Hospital, Nancy, France.
[23]
Department of Internal Medicine and Clinical Immunology, Vandoeuvre-lès-Nancy, France.
[24]
Department of pathology, Necker-Children's Hospital, AP-HP, Paris Centre University, Paris, France.
[25]
Imagine Institute, INSERM U1163, Necker-Enfants Malades University Hospital, Paris University, Paris, France.;Department of pathology, Necker-Children's Hospital, AP-HP, Paris Centre University, Paris, France.
[26]
Laboratory of Onco-Hematology, Necker Children's Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
[27]
Laboratory of Onco-Hematology, Necker Children's Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.;CNRS, INSERM U1151, Institut Necker Enfants Malades (INEM), Université Paris Cité, Paris, France.
[28]
Imagine Institute, INSERM U1163, Necker-Enfants Malades University Hospital, Paris University, Paris, France.
[29]
Hematology Laboratory, Assistance Publique-Hôpitaux de Paris, Cochin Hospital, Paris, France.;INSERM U1016, Université de Paris, Institut Cochin, Paris, France.
[30]
Rheumatology Department, Competence Center for Rare Genetic Bone Disorders, University-Hospital of Strasbourg, Strasbourg, France.
[31]
CEREMAST, the Department of Dermatology, Allergology Unit, University Hospital of Besançon, Besançon, France.
[32]
Unité Transversale Allergologie, Dermatologie, CHU Besançon - Université de Franche-Comté, EFS, INSERM, UMR RIGHT, Besançon, France.
[33]
Unité de soins et de recherche en médecine interne et maladies infectieuses, European Hospital, Marseille, France.
[34]
Department of Haematology, Sud Reunion University Hospital, Saint Pierre, France.
[35]
CEREMAST, the Department of Hematology, CHU Dupuytren, Limoges, France.
[36]
CEREMAST, the Department of Dermatology, CHU de Poitiers, Poitiers, France.
[37]
Department of Internal Medicine, Hôpital Haut-Lévêque, Université de BORDEAUX, Pessac, France.
[38]
Department of Internal Medicine, Angers University Hospital, Angers, France.
[39]
The Service d'Immunologie Clinique et d'Allergologie, Centre Hospitalier Régional Universitaire, Tours, France.
[40]
Internal Medicine Department, Centre Hospitalier Lyon Sud, Pierre-Bénite, France.;INSERM U1290, Université Lyon 1, Lyon, France.
[41]
Department of Hematology, CHU de Bordeaux, Bordeaux, France.
[42]
Service d'hématologie Oncologique et Thérapie Cellulaire, CIC-1402, CHU de Poitiers, Poitiers, France.
[43]
Department of Haematology, Hospital Centre of Roubaix, Roubaix, France.
[44]
Department of Dermatology and Allergy, Tenon Hospital, Sorbonne University, Paris, France.
[45]
Platform of Molecular Analysis for Mastocytosis and MCAD (CEREMAST), Department of Biological Hematology, Pitié-Salpêtrière Hospital, AP-HP, Paris Sorbonne University, Paris, France.
[46]
Department of Dermatology, Reference Center for Genodermatoses (MAGEC), Necker Hospital for Sick Children, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris Cité University, Paris, France.;CEREMAST, the Department of Hematology, Necker-Children's Hospital, AP-HP, Paris Centre University, Paris, France.
[47]
French Reference Center for Mastocytosis (CEREMAST), Necker-Enfants Malades University Hospital, APHP, Paris, France.;CEREMAST, the Department of Pain and Palliative Care Unit, Necker-Children's Hospital, AP-HP, Paris Centre University, Paris, France.
[48]
主题词
人类(Humans);星状孢子素(Staurosporine);男(雄)性(Male);女(雌)性(Female);中年人(Middle Aged);老年人(Aged);回顾性研究(Retrospective Studies);肥大细胞增生症, 系统性(Mastocytosis, Systemic);预后(Prognosis);成年人(Adult);世界卫生组织(World Health Organization);老年人, 80以上(Aged, 80 and over);蛋白激酶抑制剂(Protein Kinase Inhibitors);白血病, 肥大细胞(Leukemia, Mast-Cell);血液肿瘤(Hematologic Neoplasms)
DOI
10.1002/ajh.27478
PMID
39287048
发布时间
2024-10-11
- 浏览1
American journal of hematology
American journal of hematology
2127-2139页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
